SOX2 and glioblastoma: SOX2 and OCT4 are overexpressed in a variety of cancers, including breast [30], prostate [31,32], lung [33] and colorectal cancers [34], and glioblastoma [35] and have been associated with CSC subpopulations in these tumors.